PBM
Psyence Biomedical Ltd. Common SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$9.40M
P/E Ratio
—
EPS
$-389.98
Beta
1.79
52W High
$74.94
52W Low
$1.92
50-Day MA
$4.54
200-Day MA
$58.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Psyence Biomedical Ltd. Common Shares
Psyence Biomedical Ltd. (PBM) is a cutting-edge biotechnology firm focused on harnessing the therapeutic potential of psychedelic compounds to transform mental health and wellness treatments. Through its vertically integrated model, the company excels in the cultivation, formulation, and clinical research of psilocybin and other psychedelics, aiming to develop novel therapies that meet the pressing needs of patients. With a robust intellectual property portfolio and a promising clinical pipeline, Psyence is strategically positioned to leverage the increasing acceptance of psychedelics in the healthcare landscape, addressing urgent mental health challenges with innovative and effective solutions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-4.15M |
| Operating Margin | 0.00% |
| Return on Equity | -74.30% |
| Return on Assets | -34.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $39.62 |
| Price-to-Book | 0.79 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 6.32 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.29M |
| Float | 292,670 |
| % Insiders | 4.45% |
| % Institutions | 6.68% |
Historical Volatility
HV 10-Day
56.27%
HV 20-Day
61.01%
HV 30-Day
52.46%
HV 60-Day
—
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026